Skip to content

Evaluation of safety and effect of consumption of jelly drink with the cashew derived functional ingredient on changes of sleep in working age volunteers

Evaluation of safety and effect of consumption of jelly drink with the cashew derived functional ingredient on changes of sleep in working age volunteers

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230711007
Enrollment
93
Registered
2023-07-11
Start date
2023-10-06
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy condition Safety Cashew leaf Functional drink Changes of sleep Working age volunteers

Interventions

Subjects receive the placebo jelly drink which has the same color, taste and looks like the functional jelly drink.,Subjects receive the functional jelly drink containing 10 mg of the cashew derived
Placebo,Jelly drink containing 10 mg of the cashew derived functional ingredient.,Jelly drink containing 100 mg of the cashew derived functional ingredient.

Sponsors

Agricultural Research Development Agency (Public Organization)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Both male and female volunteers between 35 - 60 ages who were normal health. 2. The female subjects had normal menstrual cycles, must have expired and not receiving hormones 3. Can read and write Thai language

Exclusion criteria

Exclusion criteria: 1. Have been diagnosed with lung disease, asthma or allergies, cardiovascular disease. respiratory disease Neuropathy or head injury Gout or high uric acid, diabetes, high blood lipids High blood pressure, kidney disease, liver disease (assessed by AST or ALT values 2 times higher than normal, i.e. AST > 64 U/L; ALT > 50 U/L), cancer, immune system diseases. blood system disease and have been diagnosed with a psychiatric disorder, including Anxiety Disorder or Depression or Schizophrenia or Attention Deficit Hyperactivity Disorder or Autism or Learning Disorder. 2. Have a history of substance abuse 3. Use any medication/supplement that affects the functioning of the nervous system as instructed by the treating physician before joining the project 4. Eat fermented foods or yoghurt or probiotics more than 3 times a week. 5. Moderate strenuous exercise 3 or more days per week. 6. Use any drugs or other types of herbal medicine at least 1 month before joining the project. 7. Being pregnant or planning to become pregnant during the study 8. Breastfeeding. 9. In the process of participating in other projects.

Design outcomes

Primary

MeasureTime frame
Changes of Quality of sleep Baseline, Day1, Day7, Day28 Questionnaires of Pittsburgh Sleep Quality Index (PSQI)

Secondary

MeasureTime frame
Changes of State Worrying Baseline, Day1, Day7, Day28 State Worrying Questionnaire (PSWQ),Changes of Anxiety Baseline, Day1, Day7, Day28 Beck Anxiety Inventory (BAI),Changes of negative/postive Mood Baseline, Day1, Day7, Day28 MOSAIC Questionnaire, Safety parameters Hematology, Blood biochemical markers, Blood electrolytes, Hormones, Baseline, Day28 laboratory of hospital,Working memory test Baseline, Day7, Day28 Computerized batteries test (CDR),Working memory test Baseline, Day7, Day28 Event Related Potentials (ERPs),Body Mass Index (BMI), Body Composition and Anthropometry Baseline, Day1, Day7, Day28 laboratory of HHPHP,Electrocardiogram Baseline, Day1, Day7, Day28 laboratory of HHPHP,Changes of acetylcholinesterase (AChE), monoamine oxidase (MAO; total MAO, MAOA, MAOB, GABA transaminase ) Baseline, Day1, Day7, Day28 laboratory of HHPHP,Changes of Brain Derived Nerve Growth Factor (BDNF), and TNF-alpha Baseline, Day7, Day28 laboratory of HHPHP,No. of Lactobacillus spp., Bifidobacterium spp. in fecal sample Baseline, Day28 laboratory of HHPHP

Countries

Thailand

Contacts

Public ContactPongsatorn Paholpak

Faculty of Medicine, Khon Kaen University

ppaholpak@kku.ac.th66894221147

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026